Stay updated with breaking news from Ee Pharms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lee Pharma Ltd. announced that it has entered into a non-exclusive licensing agreement with the CSIR Indian Institute of Chemical Technology, Hyderabad (CSIR-IICT) for process know-how for the synthesis of 2-DG (2-Deoxy-D-Glucose). IICT, a constituent laboratory of the Council of Scientific and Industrial Research (CSIR) and Lee Pharma, an integrated pharmaceutical company,
CSIR-IICT, Lee Pharma join hands to produce 2-DG drug for Covid-19 patients CSIR-IICT, Lee Pharma join hands to produce 2-DG drug for Covid-19 patients Hyderabad-based CSIR-IICT and Lee Pharma have signed an agreement for synthesis of DRDO-developed anti-Covid drug 2-DG. advertisement UPDATED: June 9, 2021 18:54 IST 2-DG, developed by DRDO and Dr Reddy’s Laboratories, has received approval for use in Covid-19 treatment. (Photo: India Today/Manjeet Negi) Hyderabad-based Indian Institute of Chemical Technology, a constituent laboratory of Council of Scientific and Industrial Research (CSIR-II...